Loading...

ITOS ITEOS THERAPEUTICS INC Investor Conferences 8-K Filing

TS T

TS

ITEOS THERAPEUTICS INC

(ITOS)

2024 8-K

Show Summary

Summary

Merger of Equals

Management Changes

Divestment of Assets

Investor Presentation

Board Resignation

Clinical Data Update

Annual Meeting of Stockholders

Unregistered Sales of Equit...

Conference Presentation

Management Changes

Resignation of Chief Medica...

Resignation of Director and...

Regulatory Disclosure

Resignation of Director

Presentation at Conference

External Links:

iTeos Therapeutics announced interim clinical data from a Phase 2 study of a cancer treatment and will discuss it in a conference call on September 16, 2024.

AI Assistant

ITEOS THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.